Clinical Trials in Baltimore

Showing 2621-2640 of 11,213 trials

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

NCT00682695

The purpose of this study is to find risk factors for hemorrhagic stroke.

State University of New York at Buffalo1,000 participantsStarted Jan 2025

Chicago, Illinois, United States • Louisville, Kentucky, United States • Baltimore, Maryland, United States +4 more locations

Active Not RecruitingPhase 2< 1 mile

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

NCT05230537

The purpose of this study is to assess the effect of Iptacopan to prevent conversion of early or intermediate age-related macular degeneration (AMD) eyes to new incomplete retinal pigment epithelium and outer retinal atrophy (iRORA) or late AMD.

Age-Related Macular Degeneration

Novartis Pharmaceuticals170 participantsStarted Feb 2022

Fullerton, California, United States • Huntington Beach, California, United States • Rancho Cordova, California, United States +25 more locations

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Find Trials by Condition in Baltimore

Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI

1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

Task-dependent Effects of TMS on the Neural Biomarkers of Episodic Memory

Developing a Method to Objectively Measure Opioid Analgesia

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

STEM-PD Open Label Extension (OLE)

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

Predicting Local and Distant Recurrence in T1 Colorectal Cancer